SeptemberScience Innovation Pipeline Asset name

First Page		Document Content
Date: 2014-09-03 22:39:10 Cell biology Emerging technologies Bioengineering Cloning Tissue engineering Biorefinery Technology readiness level Virus-like particle Bioenergy Biology Biofuels Technology		SeptemberScience Innovation Pipeline Asset name Add to Reading List Source URL: www.uniquest.com.au Download Document from Source Website File Size: 330,00 KB Share Document on Facebook

	The UNM Interdisciplinary HPV Prevention Center DocID: 1rtWC - View Document
	IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s DocID: 1qztD - View Document
	SUPPLEMENT ARTICLE Impact of Ebola Mucin-Like Domain on Antiglycoprotein Antibody Responses Induced by Ebola Virus-Like Particles Osvaldo Martinez,1,a Lee Tantral,1,a Nirupama Mulherkar,2 Kartik Chandran,2 and Christoph DocID: 1q28Y - View Document
	Department of Eukaryote Genetic Engineering Senior Scientist and Head Gintautas Žvirblis, PhD DocID: 1pIGC - View Document
	IMMUNOTHERAPIES MOVING FORWARD COMPANY Agilvax is a biotechnology company developing targeted cancer stem cell immunotherapies and vaccines for infectious diseases. The company’s DocID: 1ovZf - View Document